Detalles de la búsqueda
1.
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.
Oncologist
; 27(4): 292-298, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380713
2.
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis.
Blood
; 136(12): 1433-1441, 2020 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32396939
3.
Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931).
Cancer
; 127(20): 3801-3808, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34374082
4.
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial.
Oncologist
; 26(7): 610-618, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33604969
5.
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 25(5): 380-e763, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31826977
6.
Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance).
Int J Cancer
; 145(2): 380-389, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30623420
7.
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma.
Cancers (Basel)
; 16(1)2024 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201652
8.
Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas.
Int J Radiat Oncol Biol Phys
; 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492812
9.
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.
J Clin Oncol
; 42(16): 1890-1902, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38457761
10.
Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance).
Epigenetics
; 19(1): 2349980, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38716804
11.
Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study.
Cancers (Basel)
; 15(19)2023 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835561
12.
Tumor Mutational Burden Is a Potential Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Advanced Biliary Tract Cancer.
JCO Precis Oncol
; 6: e2200003, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35772047
13.
Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance).
Epigenetics
; 17(12): 1715-1725, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35412430
14.
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma.
Target Oncol
; 17(5): 529-538, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36056231
15.
Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma.
Clin Transl Gastroenterol
; 13(10): e00523, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36000989
16.
Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma.
Cancers (Basel)
; 14(21)2022 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358592
17.
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA Netw Open
; 5(2): e2149040, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179586
18.
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial.
JCO Precis Oncol
; 6: e2200010, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35952316
19.
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer.
JNCI Cancer Spectr
; 4(3): pkaa023, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32455336
20.
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome.
J Clin Oncol
; 37(14): 1217-1227, 2019 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30865548